Office-use compounding in Wisconsin

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

What to re-check before relying on this page, and whenHigh confidence

This is the only state in this file whose office-use rule was in force, was repealed, and now sits in a vacuum awaiting a replacement that has been drafted but not adopted — Montana is also unsettled by a pending rulemaking, but its gap is different in kind, because it never had a rule to repeal. So this verdict has a shorter useful life than most and cannot be given a change date. CR 25-073 is listed as active, its public hearing was held on 18 December 2025, and it has no governor approval, no legislative-reference-bureau filing and no publication — so no adoption date exists to record here, and inventing one would be worse than saying so. If it is adopted it takes effect on the first day of the month following publication. The one hard date in the file is the expiry of its scope statement on 5 February 2027, by which point the rule has either landed or the rulemaking has lapsed. Re-fetch chapters Phar 7 and Phar 15 directly before relying on this page for anything operational, and treat any secondary source describing Wisconsin office use as pre-repeal until you have checked its date.The pending rule carries a drafting defect worth knowing about: one of its sections cites a statutory provision that was itself repealed effective 4 April 2026. That is not a reason to assume it will fail, but it is a reason not to treat the proposed text as settled.

What the current chapter actually containsHigh confidence

Three sections and nothing else: 15.01 defines the United States Pharmacopeia–National Formulary, 15.02 incorporates the USP chapters on non-sterile and sterile preparations, hazardous drugs and handling, with a flavouring carve-out, and 15.03 requires pharmacists to follow them. There is no office-use provision, no quantity cap and no label legend anywhere in it. Chapter Phar 7 was checked directly as well and contains no occurrence of "office use" or "non-patient specific".

The vacuum does not open the door — the definitional bar is untouchedHigh confidence

Section 450.01(3) defines compounding as mixing "for the purpose of dispensing"; § 450.01(7) defines dispensing as delivery "to an ultimate user" by or pursuant to a practitioner’s prescription order; and § 450.11(1) bars dispensing except on a prescription order that specifies the name and address of the patient. Compounding is tethered to dispensing and dispensing is tethered to an identified user. Office stock satisfies neither, and Wisconsin reaches that result through its own definitions rather than by deferring to federal law.

The one statutory sentence naming office use conditions itself on a rule nobody wroteHigh confidence

Section 450.01(23)(e) excludes from wholesale distribution the sale of "minimal quantities, as defined by the board in an administrative rule", of prescription drugs by retail pharmacies to licensed practitioners for office use. The board never promulgated that rule — the word "minimal" appears nowhere across the pharmacy chapters. So the only statutory text in Wisconsin naming office use depends on a definition that does not exist, and it is in any event an exemption from wholesale-distributor licensure rather than authority to compound.

The delivery problem, and it cuts against office-use shipmentsMedium confidence

Section 450.072(2)(a) bars a manufacturer or wholesale distributor from delivering prescription drugs to a person who is not licensed under § 450.071 or § 450.06 or by another state’s licensing authority, and (2)(b) confines delivery to the premises listed on the person’s licence "or authorization". A Wisconsin physician office holds neither of the named licences. Read literally this bars a licensed distributor from delivering to a prescriber’s office at all.The words "or authorization" are undefined and may be intended to reach practitioners through their professional credential. No Wisconsin case, attorney-general opinion or board interpretation resolves it. This is the most consequential open question in the state and it points the unfavourable way. The subsection carries one further exception beyond the quoted words — for a faculty member of an institution of higher education obtaining prescription drugs for instructional purposes — and it does not reach a physician practice, which is why the quotation above is marked as ending mid-provision rather than extended.

No separate veterinary limbHigh confidence

Section 450.125 routes animal-drug distribution to § 89.068, which requires a prescription specifying the species and identity of the patient, and the definition of practitioner at § 450.01(17) already includes veterinarians. Wisconsin is one of the few states reviewed here with no broader animal channel to contrast against the human one.

Entity or person — ownership-blind for the drug trades, no credential for a practiceHigh confidence

Section 990.01(26) makes "person" include corporate bodies, and § 450.071(2) contemplates partnerships, corporations and sole proprietorships as distributor licensees with no professional-ownership requirement; a pharmacy licence discloses ownership without restricting it. For a medical practice there is no entity credential to obtain: § 450.03(1)(e) exempts a person practising within the scope of a credential granted to practise medicine, and those credentials issue only to natural persons — a company cannot practise within the scope of a licence it cannot hold.The drafting contrast proves the reading. Section 450.03(1)(j), covering dialysate, expressly builds an entity path by naming an agent of a licensed person. The drafters say it when they mean it. Wisconsin has no corporate-practice-of-medicine statute: the section number sometimes cited for one does not exist, and the phrase appears only in two failed 2025 budget amendments.

One more change already datedHigh confidence

2025 Wisconsin Act 17 amends § 450.03(1)(e) on 1 September 2026 to add advanced practice registered nurses to the pharmacist-licensure exemption. It does not create an office-use pathway; it widens who would count as a practitioner able to receive office stock if and when the pending rule lands.

Wisconsin at a glance

Receiving 503B office stock in Wisconsin

Wisconsin never names outsourcing facilities anywhere in its pharmacy statutes or rules, so the credential is a wholesale distributor licence by inference rather than by category — and the statute governing who a distributor may deliver to does not appear to contemplate a prescriber’s office at all.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Wisconsin asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inMedium confidence

A Wholesale Distributor of Prescription Drugs licence from the Department of Safety and Professional Services, per facility, with a $5,000 surety bond. The department’s own credential page states that in-state and out-of-state wholesale distributors of prescription drugs must obtain a Wisconsin licence for each facility from which the drugs are distributed. A facility also filling patient-specific prescriptions into Wisconsin would separately need an out-of-state pharmacy licence under § 450.065(1).Medium because Wisconsin never names these facilities: the categorisation is an inference from the definition of wholesale distribution applied to office-use shipments, and no published departmental guidance confirms it. Beware one false friend — the phrase "outsourcing facility" does appear once in the Wisconsin Statutes, at § 255.056(1)(bd), in a list of who may donate to the state drug repository programme. A donor-eligibility list in a charitable programme run by a different department is not recognition of a licence category.

Does your practice need a permit?High confidence

There is none to obtain. Legislature-wide searches for "drug outlet", "limited drug distributor" and "terminal distributor" return no results, and the department’s complete pharmacy-board credential list runs to pharmacists, pharmacy technicians, in-state and out-of-state pharmacies, drug or device manufacturers, and wholesale distributors of prescription drugs. A physician is exempted from pharmacist licensure by § 450.03(1)(e) and needs nothing further.The absence of a permit is not entirely good news here. Because the practice holds no licence, § 450.072(2)(a) — which permits delivery only to persons holding one of two named licences — has no obvious limb covering it. In most states the absence of a permit requirement settles the receiving question; in Wisconsin it is what creates the open one.

Administer vs dispenseMedium confidence

The distinction does most of its work upstream, in the definitions: dispensing means delivery to an ultimate user pursuant to a prescription order, and compounding is defined as mixing for the purpose of dispensing. A practice administering in the office is outside the pharmacist-licensure requirement through § 450.03(1)(e) either way, so the operative constraint is on what may lawfully be supplied to it rather than on what it does afterwards.

Scheduled (controlled) stockHigh confidence

No state registration exists, and this is unusual enough to state plainly: the federal registration IS the state authority. Section 961.32(1m)(a) provides that persons registered under federal law may possess, manufacture, distribute, dispense or conduct research with controlled substances in Wisconsin to the extent authorised by their federal registration, and the board’s rule repeats it. Subchapter III of chapter 961 contains no registration section at all.The only Wisconsin-issued controlled-substance credential is a special use authorisation from the Controlled Substances Board for scientific research, instructional activities, chemical analysis or other special uses — inapplicable here, and the one place a non-pharmacy agency appears in Wisconsin’s path. Because the state authority attaches to federally registered persons, an entity holds it directly, with agents and employees covered derivatively.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• Because Phar 15.02 incorporates the USP chapters by reference, USP’s own treatment of non-patient-specific preparations is arguably the only operative standard on Wisconsin office use during the vacuum. Those chapters are copyrighted and are not retrievable here. Anyone relying on this page operationally should read the sterile chapter directly.
• The department’s reading of § 450.072(2)(a) as applied to prescriber offices is unknown. Read literally, the provision bars delivery to a physician office entirely, and we found no case, attorney-general opinion or board statement either way. This is the largest unresolved question on the page, and it is unfavourable on its face.
• Treating a 503B outsourcing facility as a wholesale distributor for Wisconsin purposes is an inference. Wisconsin never names the category, and no published departmental guidance confirms the classification.
• The pending rule’s status was read from the rulemaking record rather than from a department statement of intent. Nothing here predicts whether it will be adopted, and no adoption date exists to publish.
• We searched no case law, attorney-general opinions, board newsletters or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.